Her2/neu

The options for such patients have never been greater. They include continuing trastuzumab (Herceptin™) as the chemotherapy is switched, the substitution or addition of lapatinib for or with trastuzumab, and enrollment on clinical trials testing a large and growing number of HER2 directed novel therapies. The options for such patients have never been greater. They include continuing trastuzumab (Herceptin™) as the chemotherapy is switched, the substitution or addition of lapatinib for or with trastuzumab, and enrollment on clinical trials testing a large and growing number of HER2 directed novel therapies.